Literature DB >> 1692284

Determination of apical membrane polarity in mammary epithelial cell cultures: the role of cell-cell, cell-substratum, and membrane-cytoskeleton interactions.

G Parry1, J C Beck, L Moss, J Bartley, G K Ojakian.   

Abstract

The membrane glycoprotein, PAS-O, is a major differentiation antigen on mammary epithelial cells and is located exclusively in the apical domain of the plasma membrane. We have used 734B cultured human mammary carcinoma cells as a model system to study the role of tight junctions, cell-substratum contacts, and submembraneous cytoskeletal elements in restricting PAS-O to the apical membrane. Immunofluorescence and immunoelectronmicroscopy experiments demonstrated that while tight junctions demarcate PAS-O distribution in confluent cultures, apical polarity could be established at low culture densities when cells could not form tight junctions with neighboring cells. In such cultures the boundary between apical and basal domains was observed at the point of cell contact with the substratum. Immunocytochemical analysis of these cell-substratum contacts revealed the absence of a characteristic basement membrane containing laminin, collagen (IV), and heparan sulfate proteoglycan. However, serum-derived vitronectin was associated with the basal cell surface and the cells were shown to express the vitronectin receptor on their basolateral membranes. Additionally, treatment of cultures with antibodies against the vitronectin receptor caused cell detachment. We suggest, then, that interactions between vitronectin and its receptor, are responsible for establishment of membrane domains in the absence of tight junctions. The role of cytoskeletal elements in restricting PAS-O distribution was examined by treating cultures with cytochalasin D, colchicine, or acrylamide. Cytochalasin D led to a redistribution of PAS-O while colchicine and acrylamide did not. We hypothesize that PAS-O is restricted to the apical membrane by interactions with a microfilament network and that the cytoskeletal organization is dependent upon cell-cell and cell-substratum interactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692284     DOI: 10.1016/0014-4827(90)90174-9

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  MUC1 expressed in PanC1 cells decreases adhesion to type 1 collagen but increases contraction in collagen lattices.

Authors:  M J Hudson; G W Stamp; M A Hollingsworth; M Pignatelli; E N Lalani
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

2.  Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines.

Authors:  P A Poland; C L Kinlough; M D Rokaw; J Magarian-Blander; O J Finn; R P Hughey
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

3.  Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant.

Authors:  G D MacLean; M Reddish; R R Koganty; T Wong; S Gandhi; M Smolenski; J Samuel; J M Nabholtz; B M Longenecker
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

4.  Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene.

Authors:  L Ding; E N Lalani; M Reddish; R Koganty; T Wong; J Samuel; M B Yacyshyn; A Meikle; P Y Fung; J Taylor-Papadimitriou
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

5.  The relationship of cytoplasmic intermediate filaments and membrane antigens with hormone receptors, nuclear staining density, and mode of stromal invasion in human breast cancer.

Authors:  C D Bell; E M Tischler; G J Laroye
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

Review 6.  Prospective isolation and functional analysis of stem and differentiated cells from the mouse mammary gland.

Authors:  Joseph Regan; Matthew Smalley
Journal:  Stem Cell Rev       Date:  2007-06       Impact factor: 5.739

Review 7.  MUC1, the renaissance molecule.

Authors:  S J Gendler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.698

8.  Rise and fall of an anti-MUC1 specific antibody.

Authors:  Holger Thie; Lars Toleikis; Jiandong Li; Reinhard von Wasielewski; Gunther Bastert; Thomas Schirrmann; Isabel Tourais Esteves; Christian K Behrens; Bénédict Fournes; Nathalie Fournier; Christophe de Romeuf; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

9.  Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity.

Authors:  C H Streuli; N Bailey; M J Bissell
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

10.  MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells.

Authors:  M P Ponnusamy; A P Singh; M Jain; S Chakraborty; N Moniaux; S K Batra
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.